Inari Medical, Inc. (NARI) Stock Overview
Explore Inari Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Inari Medical, Inc. (NARI)
Key Financials
Key Financials
Market Cap
4.7B
P/E Ratio
-2776.74
EPS (TTM)
$-1.35
ROE
-0.00%
NARI Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Inari Medical, Inc. (NASDAQ: NARI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Inari Medical, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NARI on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $33.17 for the NASDAQ listing.
Key metrics behind Inari Medical, Inc.'s NASDAQ-traded stock include a P/E ratio of -2776.74 and a market capitalization of 4.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NARI on the NASDAQ.